跳至主要内容
临床试验/JPRN-UMIN000026436
JPRN-UMIN000026436已完成未知

Investigation for advanced cancer patients' treatment preferences and their end of life care - Investigation for advanced cancer patients' treatment preferences and their end of life care

agoya City University0 个研究点目标入组 400 人开始时间: 2017年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. physically too ill to complete the questionnaire 2. severe mental disorders 3. severe cognitive disorders 4. judged by the treating physician to be unsuitable to participate

研究者

发起方
agoya City University

相似试验

进行中(未招募)
1 期
A study for people with advanced colorectal cancer who have been treated with a specific chemotherapy regimen (Bevacizumab, Oxaliplatin, and a Fluoropyrimidine) which was ineffective in stopping the spread of the colorectal cancer. Study participants will receive a different chemotherapy regimen (Irinotecan, Folinic Acid, and 5-Fluorouracil) and be randomly and unknowingly assigned to also receive the study drug (ramucirimab) or a non-active compound (placebo).Metastatic Colorectal CancerMedDRA version: 17.0Level: LLTClassification code 10010036Term: Colorectal carcinomaSystem Organ Class: 100000004864
EUCTR2010-021037-32-DEEli Lilly and Company Limited, Indianapolis1,050
终止
1 期
A Phase 1 Study to Evaluate FN-1501 Monotherapy in Patients With Advanced Solid Tumors and R/R AMLAdvanced CancerSolid TumorsAcute Myeloid Leukemia RefractoryAcute Myeloid Leukemia, in Relapse
NCT03690154Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.67
终止
不适用
Assessing the Clinical Benefit of Molecular Profiling in Patients With Solid TumorsAdult Solid TumorCancerMultiple MyelomaLymphoma
NCT03061305Strata Oncology58,213
已完成
不适用
Colomid: Midkine as a predictive marker in colorectal cancer
ACTRN12613000111774Calvary Mater Newcastle Hospital33
终止
1 期
A Study to Learn How Safe BAY2666605 is, How it Affects the Body, How it Moves Into, Through and Out of the Body, the Maximum Amount That Can be Given and Its Action Against Tumors in Adult Participants With Skin Cancer That Has Spread to Other Parts of the Body and Other Types of Advanced CancerMetastatic Melanoma and Other Solid Tumors
NCT04809805Bayer5